1. Home
  2. RIOT vs PTGX Comparison

RIOT vs PTGX Comparison

Compare RIOT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riot Platforms Inc.

RIOT

Riot Platforms Inc.

HOLD

Current Price

$21.33

Market Cap

8.0B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$135.39

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIOT
PTGX
Founded
2000
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.5B
IPO Year
2002
2016

Fundamental Metrics

Financial Performance
Metric
RIOT
PTGX
Price
$21.33
$135.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
13
Target Price
$25.43
$108.23
AVG Volume (30 Days)
16.5M
631.3K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$647,435,000.00
N/A
Revenue This Year
N/A
$874.25
Revenue Next Year
$24.12
N/A
P/E Ratio
N/A
$2,711.20
Revenue Growth
71.89
N/A
52 Week Low
$10.59
$50.49
52 Week High
$30.32
$143.29

Technical Indicators

Market Signals
Indicator
RIOT
PTGX
Relative Strength Index (RSI) 44.49 59.03
Support Level $12.46 $94.48
Resistance Level $23.49 $142.20
Average True Range (ATR) 1.63 6.24
MACD 0.25 -0.97
Stochastic Oscillator 49.87 57.70

Price Performance

Historical Comparison
RIOT
PTGX

About RIOT Riot Platforms Inc.

Riot Platforms Inc is a vertically integrated digital infrastructure company principally engaged in developing and optimizing its large-scale power assets. The Company's business centers on enhancing its electrical infrastructure and deploying it across two complementary platforms: (i) Bitcoin Mining and (ii) scalable data center solutions designed to support non-mining workloads. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: